Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
Clasificación en acciones #3341
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Precio por acción
$6.27
Capitalización bursátil
$5.62B
Cambio (1 día)
-0.46%
Cambio (1 año)
26.35%
País
CN
Comercio Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Categoría

Ratio P/B de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH